The North America Iliac Stent Market would witness market growth of 5.3% CAGR during the forecast period (2023-2030).
The US market dominated the North America Others Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.7 million by 2030. The Canada market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.8% during (2023 - 2030).
Iliac stent procedures stand at the forefront of innovation, revolutionizing the treatment landscape for patients with the disease. The adoption trends in the market reflect a dynamic interplay of technological innovation, clinical evidence, regulatory considerations, and healthcare economics, shaping patterns of utilization and market dynamics.
Next-generation stent platforms offer improved radial strength, flexibility, and conformability, allowing for precise placement and optimal lesion coverage in challenging anatomies. Moreover, innovations in drug-eluting stents, bioresorbable stents, and surface-modified coatings aim to enhance patency rates, reduce restenosis, and improve long-term outcomes, driving the adoption of advanced stent technologies.
Canada has a high rate of vehicular accidents, which has raised demand for medical procedures such as the implantation of iliac stents to treat vascular problems and traumatic injuries. According to the Canadian government, in 2021, motor vehicle fatalities totalled 1,768, representing an increase of 1.3% compared to the 2020 figure of 1,746. Additionally, serious injuries from motor vehicle accidents rose by 4% to 8,185, while the total number of injuries increased by 3.6% to 1,08,018. Therefore, the increasing road traffic injuries and rapid urbanization in the region propel the market’s growth.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Others Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $38.7 million by 2030. The Canada market is experiencing a CAGR of 10.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 10.8% during (2023 - 2030).
Iliac stent procedures stand at the forefront of innovation, revolutionizing the treatment landscape for patients with the disease. The adoption trends in the market reflect a dynamic interplay of technological innovation, clinical evidence, regulatory considerations, and healthcare economics, shaping patterns of utilization and market dynamics.
Next-generation stent platforms offer improved radial strength, flexibility, and conformability, allowing for precise placement and optimal lesion coverage in challenging anatomies. Moreover, innovations in drug-eluting stents, bioresorbable stents, and surface-modified coatings aim to enhance patency rates, reduce restenosis, and improve long-term outcomes, driving the adoption of advanced stent technologies.
Canada has a high rate of vehicular accidents, which has raised demand for medical procedures such as the implantation of iliac stents to treat vascular problems and traumatic injuries. According to the Canadian government, in 2021, motor vehicle fatalities totalled 1,768, representing an increase of 1.3% compared to the 2020 figure of 1,746. Additionally, serious injuries from motor vehicle accidents rose by 4% to 8,185, while the total number of injuries increased by 3.6% to 1,08,018. Therefore, the increasing road traffic injuries and rapid urbanization in the region propel the market’s growth.
Based on Artery Lesions, the market is segmented into Common Iliac Artery Lesions, Severe Calcified Lesions, and Complete Obstructive Lesions. Based on End-use, the market is segmented into Hospitals, Outpatient Facilities, and Others. Based on Type, the market is segmented into Self-expandable Stents, Balloon-expandable Stents, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W.L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
Market Report Segmentation
By Artery Lesions- Common Iliac Artery Lesions
- Severe Calcified Lesions
- Complete Obstructive Lesions
- Hospitals
- Outpatient Facilities
- Others
- Self-expandable Stents
- Balloon-expandable Stents
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. North America Iliac Stent Market by Artery Lesions
Chapter 5. North America Iliac Stent Market by End-use
Chapter 6. North America Iliac Stent Market by Type
Chapter 7. North America Iliac Stent Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Abbott Laboratories
- Boston Scientific Corporation
- W. L. Gore & Associates, Inc.
- Medtronic PLC
- Cook Medical, Inc.(Cook Group)
- Terumo Corporation
- iVascular S.L.U.
- Getinge AB
- Biotronik SE & Co. KG
Methodology
LOADING...
